Trial Profile
An Observational Study of Patients Treated With Bimatoprost 0.03% (Latisse) for Hypotrichosis of the Eyelashes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Apr 2019
Price :
$35
*
At a glance
- Drugs Bimatoprost (Primary)
- Indications Hypotrichosis
- Focus Therapeutic Use
- Sponsors Allergan
- 17 Apr 2015 New trial record